Validation of vancomycin population pharmacokinetics modelin pediatrics

来源 :第五届定量药理学与新药评价国际会议 | 被引量 : 0次 | 上传用户:tangwu2007
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Aims: To choose a vancomycin population pharmacokinetic model most suitable for Chinese pediatric patients,in order to guide the dosage adjustment.Methods: PubMed and CN KI data were searched for studies regarding vancomycin population pharmacokinetics, and basic information were extracted.The data of patients who administered vancomycin and conducted therapeutic drug monitoring were introduced into the reported final models, and the fitting effect of the models were judged by model fitting graphics.Results: 14 vancomycin population pharmacokinetic studies from 1986-2014 were included.Model fitting graphics showed that except that models 1, 4 and 8 presented a relatively better fitting effect, the fitting effects of other models were all poor.Conclusions: After fitting Chinese pediatric patients' data into reported vancomycin population pharmacokinetic models, we found that except individual models, the fitting effects of most models were all poor, therefore it's essential to establish a vancomycin population pharmacokinetic model especially for Chinese pediatric patients, in order to guide dosage adjustment more accurately.
其他文献
  Objectives: In order to analyze the published population pharmacokinetics (PPK) models, and investigate the transferability of published models to different
会议
会议
会议
会议
Outline · Introduction The basic concept of viral dynamic model · Case study Integrated Population PK/PD Modeling of Lopinavir/Ritonavir in HIV-1 Treatment-Na
会议
会议
Systems Modeling for Translational Pharmacology Small Molecule Inhibitors of FLT3, CDK4/6 or Both Plasma PK Results Cellular Signaling Modeling Scheme pSTAT5 Da
会议
会议